Du är här

2014-04-23

Novo Nordisk A/S: Novo Nordisk A/S - Reduction of the share capital

Bagsværd, Denmark, 23 April 2014
- At Novo Nordisk's Annual General Meeting on 20 March 2014, it was decided to
reduce the company's B share capital from DKK 442,512,800 to DKK 422,512,800
by cancellation of part of the company's portfolio of own B shares at a
nominal value of DKK 20,000,000 divided into 100,000,000 B shares of DKK 0.20
each.

Further information---------------------------------------------------------------
|Media: |
|Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com |
|Ken Inchausti (US) +1 609 514 8316 kiau@novonordisk.com |
| |
|Investors: |
|Kasper Roseeuw Poulsen +45 3079 4303 krop@novonordisk.com |
|Frank Daniel Mersebach +45 3079 0604 fdni@novonordisk.com |
|Lars Borup Jacobsen +45 3075 3479 lbpj@novonordisk.com |
|Daniel Bohsen +45 3079 6376 dabo@novonordisk.com |
|Jannick Lindegaard (US) +1 609 235 8567 jlis@novonordisk.com |
---------------------------------------------------------------
Company announcement No 25 / 2014

Reduction of the share capital
http://hugin.info/2013/R/1779113/607762.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire

HUG#1779113

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.